InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,453.85
(
-1.24%
)
US TECH 100
18,492.00
(
-1.86%
)
Dow Jones
40,304.65
(
-1.32%
)
Brent Oil
80.05
(
-1.80%
)
Bitcoin
62,822.46
(
-2.75%
)
Post# of 252758
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: Bickema post# 193771

Monday, 07/27/2015 1:12:15 PM

Monday, July 27, 2015 1:12:15 PM

Post# of 252758
BLRX:

I haven't looked at them in a while. My main (only?) interest was their celiac drug. As I recall they had some tolerability issues but I don't remember if they were going to move ahead with a low dose or try to refomulate. Do you happen to know what they are doing?

On the Abbvie call they got asked about their Celiac drug and though they gave a non-answer (still looking at it and no decision reached yet) it gave me the sense they may drop it so may be one less competitor if BLRX drug has a chance.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up